1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Haemonetics Corp.

Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.
Christopher Simon

125 Summer Street
Boston, Massachusetts 02110
Phone: 17818487100


Citigroup Maintains Neutral Outlook on Haemonetics With a Target Price Set at $108.85
Oct 03, 2023 18:18pm


Citi opens upside catalyst watch for Haemonetics ahead of earnings report
Oct 02, 2023 19:15pm

Citi has opened an upside catalyst watch for Haemonetics ahead of the medtech''s FYQ2 2024 earnings report and expects management to raise guidance. Read more here.

Source:Seeking Alpha
Martingale Asset Management L P Grows Stock Holdings in Haemonetics Co. (NYSE:HAE)
Sep 03, 2023 13:02pm

Martingale Asset Management L P boosted its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 3.8% during the first quarter, Holdings Channel.com reports. The firm owned 24,921 shares of the medical instruments supplier’s stock after acquiring an additional 907 shares during the period. Martingale Asset Management L P’s holdings in Haemonetics were […]

Source:The AM Reporter
Haemonetics Receives Strong-Buy Rating and Shows Potential for Long-Term Gains
Aug 26, 2023 01:39am

In an exciting development for investors, Haemonetics (NYSE:HAE) received an upgrade by StockNews.com from a “buy” rating to a “strong-buy” rating on August 25, 2023. On Friday, shares of HAE opened at $86.43. The company’s 50-day moving average price stands at $87.87, while the 200-day moving average price is $84.26. It’s worth noting that Haemonetics […] The post Haemonetics Receives Strong-Buy Rating and Shows Potential for Long-Term Gains appeared first on Best Stocks .

Source:Best Stocks
Zacks Research Equities Analysts Decrease Earnings Estimates for Haemonetics Co. (NYSE:HAE)
Aug 25, 2023 06:54am

Haemonetics Co. (NYSE:HAE – Free Report) – Equities research analysts at Zacks Research reduced their Q4 2024 earnings per share (EPS) estimates for shares of Haemonetics in a report issued on Monday, August 21st. Zacks Research analyst R. Anand now anticipates that the medical instruments supplier will post earnings of $0.88 per share for the […]

Source:The AM Reporter
Haemonetics Corporation (HAE) Q1 2024 Earnings Call Transcript
Aug 08, 2023 15:43pm

Haemonetics Corporation (NYSE:NYSE:HAE) Q1 2024 Earnings Conference Call August 8, 2023 8:00 AM ETCompany ParticipantsOlga Guyette - Senior Director-Investor Relations &…

Source:Seeking Alpha